FEATURED COMPANIES
- Abbott Laboratories
- B. Braun Melsungen AG
- Johnson and Johnson
- Medtronic PLC
- Nihon Kohden Corporation
- Smith & Nephew
The key factors propelling the growth of the market in India are the increasing incidence of neurological disorders, huge investments by private players in neurology devices, an increase in R&D in the field of Neurotherapy, and the rising aging population.
The growth of the neurology devices market in India is also attributed to the increasing incidence of neurological disorders that include brain aneurysms, brain tumors, epilepsy, memory disorders, multiple sclerosis, Parkinson’s disease, peripheral neuropathy, post-herpetic neuralgia, spinal cord tumor, and stroke.
Moreover, the increasing healthcare spending, increasing investment by medical device manufacturers, and increasing neurological disease prevalence is expected to drive the overall Neurology Devices market growth in India.
Key Market Trends
Neurostimulation devices is expected to Dominate the Market over the Forecasted Period
Competitive Landscape
India is a developing country. As result there, increasing demand for neurology devices. This has in-turn helped market growth of neurology devices market. This has made the market more lucrative. This will encourage global players to make their presence in India.
Reasons to Purchase this report:
This product will be delivered within 2 business days.
The growth of the neurology devices market in India is also attributed to the increasing incidence of neurological disorders that include brain aneurysms, brain tumors, epilepsy, memory disorders, multiple sclerosis, Parkinson’s disease, peripheral neuropathy, post-herpetic neuralgia, spinal cord tumor, and stroke.
Moreover, the increasing healthcare spending, increasing investment by medical device manufacturers, and increasing neurological disease prevalence is expected to drive the overall Neurology Devices market growth in India.
Key Market Trends
Neurostimulation devices is expected to Dominate the Market over the Forecasted Period
- Neurostimulation devices are implantable, programmable medical devices that deliver electrical stimulation to a specific part of the patient’s brain, spinal cord or peripheral nervous system to help treat various conditions, including chronic pain, movement disorders, epilepsy, and Parkinson’s disease.
- Neuromodulation is an intracranial, electrical neuromodulation therapy that has FDA approval for the treatment for most of the neurological diseases such as bladder control, headache, tremors, chronic pain, stroke, minimally conscious state, and spinal cord injury, which are most commonly found in the elderly population.
- In India, the geriatric population is rising. As a result, the incidence of neurological disorders is also expected to rise in India. Hence it is expected that the demand for these devices is expected to increase in the future.
Competitive Landscape
India is a developing country. As result there, increasing demand for neurology devices. This has in-turn helped market growth of neurology devices market. This has made the market more lucrative. This will encourage global players to make their presence in India.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format.
months of analyst support.
This product will be delivered within 2 business days.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Laboratories
- B. Braun Melsungen AG
- Johnson and Johnson
- Medtronic PLC
- Nihon Kohden Corporation
- Smith & Nephew
1 INTRODUCTION
4 MARKET DYNAMICS
5 MARKET SEGMENTATION
6 COMPETITIVE LANDSCAPE
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Abbott Laboratories
- B. Braun Melsungen AG
- Boston Scientific Corporation
- Johnson and Johnson
- Medtronic PLC
- MicroPort Scientific Corporation
- Nihon Kohden Corporation
- Smith & Nephew
- Stryker Corporation
Note: Product cover images may vary from those shown
LOADING...